| Sources | Names Used |
|---|---|
| GDSC1000 | HG-5-88-01 |
| PharmacoGx | HG-5-88-01 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NCAM2 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | TRHDE | GDSC1000 | pan-cancer | AAC | 0.085 | 0.09 |
| mRNA | LCE2C | GDSC1000 | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | VPS52 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | CPO | GDSC1000 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | PACSIN3 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | AGTR2 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.09 |
| mRNA | T | GDSC1000 | pan-cancer | AAC | -0.076 | 0.09 |
| mRNA | MRPL9 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | ENDOD1 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.09 |
